Serial #50141840
LIVE

Serial Number

50141840

Owner

Replay Holdings, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Oct 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #50141840 Trademark

Serial Number: 50141840

Serial #50141840 is a trademark filed by Replay Holdings, Inc. on October 2, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Replay Holdings, Inc.

5555 Oberlin Drive, Suite 120
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

October 2, 2026

Registration Date

Not Registered

Goods & Services

Educational services, namely, conducting seminars, conferences, workshops, classes, and training programs in the fields of pharmaceuticals, biotechnology, gene therapy, cell therapy, genome engineering, and enzyme preparations; providing online, non-downloadable educational publications in the foregoing fields; publication of educational materials in the pharmaceutical and biotechnology fields

Pharmaceutical products for cell therapy to treat human diseases and disorders; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human diseases and disorders; pharmaceutical preparations for gene therapy to treat human diseases and disorders; gene therapy preparations to treat human diseases and disorders; enzyme preparations for medical purposes to treat human diseases and disorders; enzymes for medical purposes to treat human diseases and disorders; enzymes for veterinary purposes to treat human diseases and disorders; animal feed additives, namely, enzymes for use in animal feeds to assist in digestion; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy

Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, and engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific testing, inspection, research, and development of enzyme preparations for gene and cell therapy; scientific research and development of DNA delivery technology for purposes of providing gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of new technology in the field of cell therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for cell therapy

Enzymes for scientific and research purposes; Enzymes for use in the food industry; Enzymes for use in the manufacture of pet food; Enzymes derived from biotechnological processes for use in industry; Chemical preparations for scientific purposes; Chemical preparations for use in industry; Enzymes for industrial purposes

Wholesale services featuring pharmaceutical preparations, medical preparations, gene therapy preparations, cell therapy products, and enzyme preparations

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 2, 2026 MAFR
NEW APPLICATION ENTERED
Oct 2, 2026 NWAP